Yüklüyor......
Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations
The EGFR exon 20 insertion (EGFRex20ins) mutations are the third most common EGFR mutations seen in non-small cell lung cancer (NSCLC). More than 50 variants of EGFRex20ins mutations have been identified with A767_V769dupASV being the most common variant across multiple surveys. Treatment with curre...
Kaydedildi:
| Yayımlandı: | Lung Cancer (Auckl) |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8286072/ https://ncbi.nlm.nih.gov/pubmed/34285620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S307321 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|